A major collaboration between the Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative is set to ...

The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable ...

French ophthalmology company Nicox (EPA: ALCOX) has signed an agreement with Japan’s Kowa Company (TYO: 7807).

French biotech One Biosciences has raised 15 million euros ($16 million) in series A financing to advance development of its ...

Spanish plasma-derived medicines specialist Grifols saw its share close up 7% yesterday, after it revealed that it will ...

The Bristol Myers Squibb-Pfizer Alliance today announced a new direct-to-patient option for purchasing Eliquis (apixaban) via ...

South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...

US companies SandboxAQ and iOncologi have announced a strategic collaboration to jointly develop, validate, and commercialize ...

UK pharma major GSK has gained US regulatory approval for a new prefilled syringe presentation of its shingles vaccine, ...

Artificial intelligence has edged past the pilot phase in clinical development. Once a niche add-on, AI is now helping ...

Bayer (BAYN: DE) is giving chief executive Bill Anderson more time to deliver on his ambitious efforts to reshape the German ...

Sweden’s OncoZenge has announced an amendment to its license and supply agreement with Italian firm Molteni Farmaceutici.